Clinical Trials
3 trialsNCT03854318 2026-06-05
Longitudinal Studies of Patient With FPDMM
National Institutes of Health Clinical Center (CC)
Recruiting
NCT02834013 2026-06-03
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT06714370 2026-05-20
REVEAL
Ono Pharmaceutical Co., Ltd.
Completed